Precision Medicine

Multidisciplinary Lung Cancer Tumor Board: Management of Surgically Resected Early-Stage EGFRm NSCLC

Charu Aggarwal, MD, MPH; Tina Cascone, MD, PhD
Recent Advances in the Treatment of Advanced HER2+ GEJ Cancers

Tanios S. Bekaii-Saab, MD
Treatment of NSCLC in Special Populations – PDL1 negative, STK11/KEAP

Charu Aggarwal, MD, MPH
Targeting KRAS in Pancreatic Cancer: Current Opportunities

Tanios S. Bekaii-Saab, MD
Expanding Opportunities to Target RAS in Pancreatic Cancer

Tanios S. Bekaii-Saab, MD
Multidisciplinary Lung Cancer Tumor Board: Management of Early Stage EGFRm NSCLC

Charu Aggarwal, MD, MPH; Brendon Stiles, MD
Pancreatic Cancer and Molecular/Genetic Testing: Challenges and Opportunities

Tanios S. Bekaii-Saab, MD
Precision Oncology in Bladder Cancer: FGFR3 Inhibitors

Tian Zhang, MD, MHS
Integrating Precision Oncology in Prostate Cancer: Current Role of PARP Inhibitors and Combinations

Tian Zhang, MD, MHS
Emerging Treatment Landscape for BRAF V600E Mutated Colon Cancer

John Strickler, MD
Emerging Role of Fibroblast Growth Factor Receptor 2b (FGFR2b) Inhibitors in Gastroesophageal Cancers

Tanios S. Bekaii-Saab, MD
2025 Update on Management of NTRK Fusions

Martin F. Dietrich, MD, PhD